About Khalili Lab
Welcome to Khalili Lab, where our passion for liver health drives groundbreaking research and innovation. Dedicated to unraveling the complexities of hepatology, we are at the forefront of scientific exploration, seeking solutions to combat liver diseases and improve patient outcomes worldwide.
At Khalili Lab, our multidisciplinary team of researchers, clinicians, and experts collaborate tirelessly to push the boundaries of knowledge in hepatology. From understanding the molecular mechanisms of liver diseases to developing novel therapeutics and diagnostic tools, our work spans the spectrum of liver health.
Mandana Khalili, MD
I am the Co-Director of the UCSF Clinical and Translational Science Institute-Mentor Training Program (https://accelerate.ucsf.edu/training/mtp) aimed at training faculty to become effective research mentors. I also serve as the Co-Director of UCSF Hepatology T32 program focused on training research fellows. I have an NIH funded-K24 mentoring grant aimed at supporting the research careers of early investigator trainees and junior faculty in the area of patient oriented research and my clinical/ translational research program serves as the infrastructure and the backbone for supporting research training and research activities (including biostatistical support) of trainees and junior faculty. I actively participate in the education and research mentoring of trainees and serve as a senior faculty for the Hepatology and also psychiatry T32-Research Training grants. In addition, I co-lead the Gastroenterology Fellow Research Conferences and training aimed at enhancing the research training and progress of our fellows in the UCSF Division of Gastroenterology and Hepatology. Further, I co-lead the CTSI-T32 fellow training seminars for gastroenterolgy, hepatology and renal fellows. My research expertise includes both translational and clinical components with a longstanding track record of independent extramural funding in epidemiology and pathogenesis of liver disease (including viral hepatitis, fatty liver disease, alcohol-related liver disease), and metabolic manifestations. We also have a specific focus in addressing health disparities in underserved populations and both health services and implementation science. My research expertise, long-standing track record of successful research and career mentoring of trainees and junior faculty and leadership roles in mentoring along with extensive collaborative network of leaders in liver disease and related fields will ensure successful completion of the research and mentoring goals of the mentees at all career levels.
Publications
The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts. Mod Pathol. 1992 Mar; 5(2):158-64.Wolfsohn AL, Walley VM, Davies RA, Keon CA, Khalili M, Keon WJ. PMID: 1574494.
Ionescu-Shiley valve failure. I: Experience with 125 standard-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):111-6.Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. PMID: 1610221.
Ionescu-Shiley valve failure. II: Experience with 25 low-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):117-22; discussion 122-3.Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. PMID: 1610222.
Trabeculectomy: a retrospective follow-up of 700 eyes. Int Ophthalmol. 1998-1999; 22(4):211-20.Diestelhorst M, Khalili MA, Krieglstein GK. PMID: 10674865.
Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. Am J Gastroenterol. 2000 May; 95(5):1284-9.Khalili M, Denham C, Perrillo R. PMID: 10811340.